Therapeutic Climbing for Children With DCD (Climbing TDC)
27 de maio de 2026 atualizado por: Université de Sherbrooke
Therapeutic Group Climbing for Children With Developmental Coordination Disorder: Randomized Crossover Trial
This study looks at whether therapeutic climbing - indoor climbing activities guided by therapists - can help children with Developmental Coordination Disorder (DCD).
DCD is a condition where children have difficulty with motor skills and participation in everyday activities, and sometimes confidence in physical activities.
The climbing program is based on a problem-solving approach called CO-OP (Cognitive Orientation to daily Occupational Performance), in which children learn strategies to achieve goals.
Visão geral do estudo
Status
Ainda não está recrutando
Intervenção / Tratamento
Descrição detalhada
Background: Therapeutic climbing, based on the Cognitive Orientation to daily Occupational Performance (CO-OP) approach, may improve goal performance and satisfaction in children with Developmental Coordination Disorder (DCD), as well as their motivation and self-efficacy toward physical activity.
Objective: This study aims to examine the effectiveness of a CO-OP-based group therapeutic climbing intervention for children with DCD.
Methods: A randomized crossover trial will be conducted with children with DCD. The intervention will consist of a 10-week group-based therapeutic climbing program delivered in an indoor climbing setting. Primary outcomes will include performance and satisfaction related to individualized goals. Secondary outcomes will assess motor skills, self-efficacy, executive functions, motivation toward physical activity, and transfer of learning. Effects of the intervention will be assessed using linear mixed effects models.
Results: It is hypothesized that participants will demonstrate improvements in both primary and secondary outcomes following the intervention.
Conclusions: This study will contribute to the evidence base regarding therapeutic climbing and CO-OP-based interventions for children with DCD, informing future rehabilitation practices.
Tipo de estudo
Intervencional
Inscrição (Estimado)
16
Estágio
- Não aplicável
Contactos e Locais
Esta seção fornece os detalhes de contato para aqueles que conduzem o estudo e informações sobre onde este estudo está sendo realizado.
Contato de estudo
- Nome: Emmanuelle Jasmin, Ph.D.
- Número de telefone: 1-819-342-0305
- E-mail: emmanuelle.jasmin@usherbrooke.ca
Critérios de participação
Os pesquisadores procuram pessoas que se encaixem em uma determinada descrição, chamada de critérios de elegibilidade. Alguns exemplos desses critérios são a condição geral de saúde de uma pessoa ou tratamentos anteriores.
Critérios de elegibilidade
Idades elegíveis para estudo
- Filho
Aceita Voluntários Saudáveis
Não
Descrição
Inclusion Criteria:
- Diagnosis of DCD by a physician*.
- Ability to follow instructions, communicate verbally, interact with adults and peers, and use cognitive strategies.
- Ability to attend all assessment and intervention sessions in Sherbrooke.
- Ability to understand and speak French.
- Provision of child assent and parental consent. * If the target sample size (n = 16) is not reached, children with suspected DCD based on the Developmental Coordination Disorder Questionnaire (DCDQ) (25,26) will also be considered. Eligibility will then require: (1) a score below the 15th percentile on the total motor composite or below the 5th percentile in a domain of the Bruininks-Oseretsky Test of Motor Proficiency (BOT) (27,28), and (2) the identification of occupational challenges using the Canadian Occupational Performance Measure (COPM) (29,30) during the initial assessment.
Exclusion Criteria:
- Diagnosis of severe behavioral disorders, autism spectrum disorder, intellectual disability, cerebral palsy, muscular dystrophy, and/or severe functional limitations.
- Prior proficiency in climbing or absence of climbing-related goals.
Plano de estudo
Esta seção fornece detalhes do plano de estudo, incluindo como o estudo é projetado e o que o estudo está medindo.
Como o estudo é projetado?
Detalhes do projeto
- Finalidade Principal: Tratamento
- Alocação: Randomizado
- Modelo Intervencional: Atribuição cruzada
- Mascaramento: Nenhum (rótulo aberto)
Armas e Intervenções
Grupo de Participantes / Braço |
Intervenção / Tratamento |
|---|---|
|
Experimental: Group 1 - Fall 2026
First group intervention
|
The intervention will consist of a 10-week group-based therapeutic climbing program delivered once weekly on Saturday afternoons at an indoor climbing center.
Sessions will be delivered by an occupational therapist (OT), two occupational therapy interns, and a certified climbing monitor (hereafter referred to as "intervention providers").
Each 90-minute session will follow the same global structure.
The intervention is grounded in the CO-OP approach.
|
|
Experimental: Group 2 - Winter 2027
Second group intervention
|
The intervention will consist of a 10-week group-based therapeutic climbing program delivered once weekly on Saturday afternoons at an indoor climbing center.
Sessions will be delivered by an occupational therapist (OT), two occupational therapy interns, and a certified climbing monitor (hereafter referred to as "intervention providers").
Each 90-minute session will follow the same global structure.
The intervention is grounded in the CO-OP approach.
|
O que o estudo está medindo?
Medidas de resultados primários
Medida de resultado |
Descrição da medida |
Prazo |
|---|---|---|
|
Performance related to individualized goals
Prazo: Baseline (2-3 months before the intevention, pre-intervention (immediatly before the intervention), post-intervention (immediatly after the intervention), follow-up 2-3 months post-intervention
|
Assess with the Canadian Occupational Performance Measure (COPM) (visual analog scale of 1-10)
|
Baseline (2-3 months before the intevention, pre-intervention (immediatly before the intervention), post-intervention (immediatly after the intervention), follow-up 2-3 months post-intervention
|
|
Satisfaction related to individualized goals
Prazo: Baseline (2-3 months before the intervention, pre-intervention (immediatly before the intervention), post-intervention (immediatly after the intervention), follow-up 2-3 months post-intervention
|
Assess with the Canadian Occupational Performance Measure (COPM) (visual analog scale of 1-10)
|
Baseline (2-3 months before the intervention, pre-intervention (immediatly before the intervention), post-intervention (immediatly after the intervention), follow-up 2-3 months post-intervention
|
|
Performance related to climbing-specific goals
Prazo: Baseline (2-3 months before the intervention, pre-intervention (immediatly before the intervention), post-intervention (immediatly after the intervention), follow-up 2-3 months post-intervention
|
Assess with the Performance Quality Rating Scale (PQRS) (visual analog scale of 1-10)
|
Baseline (2-3 months before the intervention, pre-intervention (immediatly before the intervention), post-intervention (immediatly after the intervention), follow-up 2-3 months post-intervention
|
Medidas de resultados secundários
Medida de resultado |
Descrição da medida |
Prazo |
|---|---|---|
|
Motor skills
Prazo: Baseline (2-3 months before the intervention, pre-intervention (immediatly before the intervention), post-intervention (immediatly after the intervention), follow-up 2-3 months post-intervention
|
Bruininks-Oseretsky Test of Motor Proficiency, Third Edition (BOT-3) (standard scores (mean = 50, SD = 10) or scale scores for subtests (mean = 10, SD = 3))
|
Baseline (2-3 months before the intervention, pre-intervention (immediatly before the intervention), post-intervention (immediatly after the intervention), follow-up 2-3 months post-intervention
|
|
Self-efficacy
Prazo: Baseline (2-3 months before the intervention, pre-intervention (immediatly before the intervention), post-intervention (immediatly after the intervention), follow-up 2-3 months post-intervention
|
Assess with the French adaptation of the General Self-Efficacy Scale (GSES) (5-point Likert scale)
|
Baseline (2-3 months before the intervention, pre-intervention (immediatly before the intervention), post-intervention (immediatly after the intervention), follow-up 2-3 months post-intervention
|
|
Executive functioning
Prazo: Baseline (2-3 months before the intervention, pre-intervention (immediatly before the intervention), post-intervention (immediatly after the intervention), follow-up 2-3 months post-intervention
|
Assess with the Behavior Rating Inventory of Executive Function, Second Edition (BRIEF-2) T-scores (mean = 50, SD = 10)
|
Baseline (2-3 months before the intervention, pre-intervention (immediatly before the intervention), post-intervention (immediatly after the intervention), follow-up 2-3 months post-intervention
|
|
Motivation for physical activity
Prazo: Baseline (2-3 months before the intervention, pre-intervention (immediatly before the intervention), post-intervention (immediatly after the intervention), follow-up 2-3 months post-intervention
|
Assess with the Pictorial Motivation Scale (PMS) for physical activity (3-point scale)
|
Baseline (2-3 months before the intervention, pre-intervention (immediatly before the intervention), post-intervention (immediatly after the intervention), follow-up 2-3 months post-intervention
|
Colaboradores e Investigadores
É aqui que você encontrará pessoas e organizações envolvidas com este estudo.
Patrocinador
Investigadores
- Investigador principal: Emmanuelle Jasmin, Ph.D., Université de Sherbrooke
Datas de registro do estudo
Essas datas acompanham o progresso do registro do estudo e os envios de resumo dos resultados para ClinicalTrials.gov. Os registros do estudo e os resultados relatados são revisados pela National Library of Medicine (NLM) para garantir que atendam aos padrões específicos de controle de qualidade antes de serem publicados no site público.
Datas Principais do Estudo
Início do estudo (Estimado)
15 de maio de 2026
Conclusão Primária (Estimado)
6 de junho de 2026
Conclusão do estudo (Estimado)
6 de junho de 2026
Datas de inscrição no estudo
Enviado pela primeira vez
12 de maio de 2026
Enviado pela primeira vez que atendeu aos critérios de CQ
19 de maio de 2026
Primeira postagem (Real)
27 de maio de 2026
Atualizações de registro de estudo
Última Atualização Postada (Real)
1 de junho de 2026
Última atualização enviada que atendeu aos critérios de controle de qualidade
27 de maio de 2026
Última verificação
1 de maio de 2026
Mais Informações
Termos relacionados a este estudo
Palavras-chave
Termos MeSH relevantes adicionais
Outros números de identificação do estudo
- 2026-6195
- Mental health 2025-2026 (Outro identificador: Pediatric Research Foundation)
Plano para dados de participantes individuais (IPD)
Planeja compartilhar dados de participantes individuais (IPD)?
NÃO
Informações sobre medicamentos e dispositivos, documentos de estudo
Estuda um medicamento regulamentado pela FDA dos EUA
Não
Estuda um produto de dispositivo regulamentado pela FDA dos EUA
Não
Essas informações foram obtidas diretamente do site clinicaltrials.gov sem nenhuma alteração. Se você tiver alguma solicitação para alterar, remover ou atualizar os detalhes do seu estudo, entre em contato com register@clinicaltrials.gov. Assim que uma alteração for implementada em clinicaltrials.gov, ela também será atualizada automaticamente em nosso site .